| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.88 | $53.08 (0%) | 🛒 Add to cart |
| 90 | $0.81 | $79.62 $73.11 (8%) | 🛒 Add to cart |
| 120 | $0.78 | $106.16 $93.14 (12%) | 🛒 Add to cart |
| 180 | $0.75 | $159.24 $134.20 (16%) | 🛒 Add to cart |
| 270 | $0.72 | $238.85 $194.29 (19%) | 🛒 Add to cart |
| 360 | $0.71
Best per pill | $318.47 $254.38 (20%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
trazodone
Trazodone hydrochloride is a triazolopyridine derivative antidepressant that’s been in clinical use since the 1980s, though its applications have expanded significantly beyond its original indication. What’s fascinating about this molecule is how it’s evolved from a second-line antidepressant to a versatile therapeutic agent with multiple off-label uses that often overshadow its primary indication. The chemical structure features a phenylpiperazine moiety that gives it unique receptor binding properties distinct from other antidepressants.
desyrel
Let me walk you through what we’ve learned about Desyrel over the years - this isn’t the polished pharmaceutical brochure version, but what actually happens in clinical practice. I’ve been prescribing trazodone (the generic name for Desyrel) since my residency in the late 1990s, and the evolution of how we use this medication tells a more interesting story than the official prescribing information suggests. Desyrel contains trazodone hydrochloride as its active component, functioning primarily as a serotonin antagonist and reuptake inhibitor (SARI).
fluoxetine
Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), has been a cornerstone in psychopharmacology since its approval. Initially developed as an antidepressant, its applications have expanded significantly over decades of clinical use. The molecule’s unique pharmacokinetic profile—notably its active metabolite norfluoxetine with an extended half-life—creates both therapeutic advantages and clinical challenges that every prescriber needs to understand intimately. Fluoxetine: Comprehensive Management of Depression and Related Disorders - Evidence-Based Review 1. Introduction: What is Fluoxetine?
Sinequan: Effective Management of Depression and Insomnia - Evidence-Based Review
Sinequan, known generically as doxepin, is a tricyclic antidepressant (TCA) that has been a cornerstone in psychopharmacology for decades. Initially approved for major depressive disorder, its utility has expanded due to its potent histamine H1 receptor antagonism, making it particularly valuable for treating chronic insomnia, especially in cases where sedation is desired without significant anticholinergic burden. It’s available in various formulations, including oral capsules and a concentrated oral solution, with dosing tailored to the indication—lower doses (3-6 mg) for insomnia and higher doses (75-150 mg) for depression.
a ret gel
A topical retinoid formulation combining tretinoin 0.025% in a novel hydrogel delivery system designed for enhanced epidermal penetration while minimizing irritation. The gel matrix incorporates humectants and barrier-supporting ceramides to counteract the drying effects typical of traditional retinoid therapies. We initially developed this formulation after observing consistent patient complaints about the irritation and peeling associated with conventional tretinoin creams - honestly, our first three prototypes were complete failures that left our test subjects with significant erythema and scaling.
Abana: Comprehensive Cardiovascular Support Through Herbal Synergy - Evidence-Based Review
Product Description: Abana represents one of those formulations that initially seemed almost too good to be true when I first encountered it during my cardiology rotation in New Delhi back in 2004. This comprehensive herbal formulation, developed through rigorous Ayurvedic principles combined with modern pharmacological understanding, serves as a cardioprotective and lipid-normalizing agent. What struck me initially wasn’t just the ingredient list but the sophisticated delivery system that seemed to enhance bioavailability beyond what I’d seen with similar herbal preparations.
abhigra
Product Description: Abhigra is a novel dietary supplement formulation specifically engineered to address chronic inflammatory conditions through a multi-targeted approach. The product combines standardized botanical extracts with enhanced bioavailability components, designed for patients who haven’t responded adequately to conventional anti-inflammatory regimens. What makes Abhigra particularly interesting isn’t just the ingredient profile - it’s the specific ratios and delivery system that took our team nearly three years to perfect. We initially struggled with the curcuminoid stability issue - kept getting inconsistent plasma levels in our early pharmacokinetic studies.
abilify
Aripiprazole represents one of the most fascinating psychopharmacological developments of the past two decades - a third-generation antipsychotic that functions as a partial dopamine agonist rather than a pure antagonist. When I first encountered this mechanism during my residency, the concept seemed almost paradoxical: how could a medication simultaneously treat psychosis while having potential antidepressant properties? The answer lies in its unique receptor profile that allows it to act as a functional stabilizer rather than simply blocking or stimulating neurotransmitter systems.
acamprol
In my early neurology practice, we had a significant cohort of patients with chronic neuropathic pain and spasticity who weren’t responding well to conventional treatments. I remember specifically working with a 62-year-old retired teacher named Margaret who had developed debilitating spasticity following a spinal cord injury. She’d been through the usual gabapentin, baclofen, even tried botulinum toxin injections with limited success and significant side effects. That’s when our research team began investigating acamprol as a potential alternative.